raloxifene hydrochloride has been researched along with melitten in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fabris, V; Helguero, LA; Lamb, CA; Lanari, C; Lucas, C; Molinolo, AA | 1 |
| Abualsunun, W; Ahmed, OAA; Aldawsari, HM; Alhakamy, NA; Badr-Eldin, SM; Eid, BG; El Sherbiny, GA; Fahmy, UA; Radwan, MF; Sayed, SRM | 1 |
2 other study(ies) available for raloxifene hydrochloride and melitten
| Article | Year |
|---|---|
Differential effects of raloxifene, tamoxifen and fulvestrant on a murine mammary carcinoma.
Topics: Animals; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Chorionic Gonadotropin, beta Subunit, Human; Estradiol; Estrogen Receptor Modulators; Female; Medroxyprogesterone Acetate; Melitten; Mice; Mice, Inbred BALB C; Raloxifene Hydrochloride; Receptors, Progesterone; Tamoxifen; Tumor Cells, Cultured | 2003 |
Potentiality of raloxifene loaded melittin functionalized lipidic nanovesicles against pancreatic cancer cells.
Topics: bcl-2-Associated X Protein; Humans; Melitten; Pancreatic Neoplasms; Phospholipids; Raloxifene Hydrochloride | 2022 |